Is ABBV or BMY cheaper?

On trailing earnings, BMY is cheaper: ABBV trades at a 111.67 P/E and BMY at 16.05.

Which has grown faster, ABBV or BMY?

Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus BMY at 2.52%.

Does ABBV or BMY pay a bigger dividend?

ABBV yields 2.96% and BMY yields 4.38% based on trailing dividends and the latest price.

Is ABBV or BMY more profitable?

BMY runs the higher net margin — ABBV at 5.79% versus BMY at 15.01%.

Which has been the better investment, ABBV or BMY?

Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus BMY at 1.08%. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Bristol-Myers Squibb Company (BMY)

BMY leads on 10 of 15 compared metrics.

A side-by-side comparison of AbbVie Inc. and Bristol-Myers Squibb Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Bristol-Myers Squibb Company

$116.66B

$57.13Healthcare

Total return — ABBV vs BMY

growth of $100 · last 14y

ABBV +544.8%BMY +72.8%ABBV compounded faster

ABBV BMY

ABBV vs BMY: by the numbers

•ABBV is the larger company ($402.35B vs $116.66B market cap).
•BMY trades at the lower earnings multiple (16.05 vs 111.67 P/E).
•BMY converts more revenue to profit (15.01% vs 5.79% net margin).
•ABBV grew revenue faster over the past five years (4.59% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.38% vs 2.96%).

Which is better, ABBV or BMY?

Metric tally: ABBV 5 · BMY 10

It depends on what you're optimizing for:

ValueBMY(lower P/E)

GrowthABBV(faster 5Y revenue CAGR)

IncomeBMY(higher dividend yield)

QualityBMY(higher ROIC)

Valuation

Metric	ABBV	BMY
P/E ratio	111.67	16.05●
Forward P/E	—	9.31
P/S ratio	6.43	2.41●
P/B ratio	14.69	5.82●
PEG ratio	—	1.71
EV / EBITDA	27.63	11.03●
FCF yield	5.17%	10.20%●

Profitability

Metric	ABBV	BMY
Gross margin	70.68%●	68.75%
Operating margin	27.60%●	25.67%
Net margin	5.79%	15.01%●
ROE	13.23%	36.25%●
ROIC	12.97%	13.90%●

Dividends

Metric	ABBV	BMY
Dividend yield	2.96%	4.38%●
Payout ratio	284.39%	72.25%

Growth (annualized)

Metric	ABBV	BMY
Revenue CAGR (5Y)	4.59%●	2.52%
EPS CAGR (5Y)	-2.79%	9.38%●
FCF CAGR (5Y)	3.24%●	-2.50%
Total return CAGR (5Y)	18.95%●	0.74%

Frequently asked

Which is better, ABBV or BMY?: It depends on your goal. value: BMY (lower P/E); growth: ABBV (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: BMY (higher ROIC). Across all compared metrics, BMY leads 10 to 5.
Is ABBV or BMY cheaper?: On trailing earnings, BMY is cheaper: ABBV trades at a 111.67 P/E and BMY at 16.05.
Which has grown faster, ABBV or BMY?: Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus BMY at 2.52%.
Does ABBV or BMY pay a bigger dividend?: ABBV yields 2.96% and BMY yields 4.38% based on trailing dividends and the latest price.
Is ABBV or BMY more profitable?: BMY runs the higher net margin — ABBV at 5.79% versus BMY at 15.01%.
Which has been the better investment, ABBV or BMY?: Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus BMY at 1.08%. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full BMY analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Bristol-Myers Squibb P/E ratio AbbVie dividend yield Bristol-Myers Squibb dividend yield AbbVie ROE Bristol-Myers Squibb ROE AbbVie operating margin Bristol-Myers Squibb operating margin AbbVie revenue growth Bristol-Myers Squibb revenue growth AbbVie free cash flow Bristol-Myers Squibb free cash flow

AbbVie & Bristol-Myers Squibb appear in these rankings

Highest Dividend Yield Stocks Dividend Aristocrats Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.